<p>(A) IL12α, (B) TNF-α, (C) IL-1B, (D) IL-6. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘Periparasitic liver tissue’ versus ‘Control’. *<i>P</i><0.05; **<i>P</i><0.01. ‘Control’, non-infected mice; ‘Parasitic lesion’: <i>E. multilocularis</i> metacestode and surrounding immune infiltrate; ‘Periparasitic liver tissue: liver parenchyma close to the <i>E. multilocularis</i> lesion, but excluding macroscopically visible liver tissue alterations. AU: arbitrary units.</p
<p>BALB/c mice were treated with 1 µg/mouse IL-12 (solid square) or vehicle control (VC; open triang...
<p>BALB/c mice were injected i.v. with 5x10<sup>5</sup> PFU of WT MCMV (MW97.01) and liver tissue wa...
<p>A: Course of TGF-<i>β</i>1 expression observed by immune-staining in the liver from <i>E. multilo...
<p>(A) IFN-γ, (B) CXCL9, (C) CXCL10, (D) CXCL12. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘Peripar...
<p>(A) IL-4, (B) IL-5, (C) CCL8, (D) CCL12, (E) CCL17. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘P...
<p>(A) Foxp3, (B) TGF-β1, (C) IL-10. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘Periparasitic liver...
<p>Course of the changes in the morphology of the hepatic lesions (a), gene expression of innate imm...
<p>(A). Expression of IL-17 at day 90. IL-17 was present in most of the infiltrating lymphocytes of ...
<p>Livers obtained from mice in the different groups were obtained on day 14-16 post-cDNA treatment....
<p>(A) There was a significantly higher level of IL1β in GFPWT:WT mice treated with LPS compared to ...
<p>Immune compromised female BALB/c mice (n = 3 per group) were infected with 1×10<sup>5</sup> PFU o...
<p>(A and B) LysM- PPARγ<sup>WT</sup> and LysM- PPARγ<sup>KO</sup> mice were infected i.p. with 2×10...
<p>(<b>A</b>) B6 mice (black bar) or GzmB<sup>W/W</sup> mice (white bar) were infected with Δm157 MC...
<p>Western blot analyses were performed on lysates from liver samples with antibodies that recognize...
<p>C57BL/6J mice were left uninfected or were infected with <i>Pb</i>ANKA, <i>Pb</i>NK65 or <i>Pc</i...
<p>BALB/c mice were treated with 1 µg/mouse IL-12 (solid square) or vehicle control (VC; open triang...
<p>BALB/c mice were injected i.v. with 5x10<sup>5</sup> PFU of WT MCMV (MW97.01) and liver tissue wa...
<p>A: Course of TGF-<i>β</i>1 expression observed by immune-staining in the liver from <i>E. multilo...
<p>(A) IFN-γ, (B) CXCL9, (C) CXCL10, (D) CXCL12. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘Peripar...
<p>(A) IL-4, (B) IL-5, (C) CCL8, (D) CCL12, (E) CCL17. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘P...
<p>(A) Foxp3, (B) TGF-β1, (C) IL-10. a: ‘Parasitic lesion’ versus ‘Control’; b: ‘Periparasitic liver...
<p>Course of the changes in the morphology of the hepatic lesions (a), gene expression of innate imm...
<p>(A). Expression of IL-17 at day 90. IL-17 was present in most of the infiltrating lymphocytes of ...
<p>Livers obtained from mice in the different groups were obtained on day 14-16 post-cDNA treatment....
<p>(A) There was a significantly higher level of IL1β in GFPWT:WT mice treated with LPS compared to ...
<p>Immune compromised female BALB/c mice (n = 3 per group) were infected with 1×10<sup>5</sup> PFU o...
<p>(A and B) LysM- PPARγ<sup>WT</sup> and LysM- PPARγ<sup>KO</sup> mice were infected i.p. with 2×10...
<p>(<b>A</b>) B6 mice (black bar) or GzmB<sup>W/W</sup> mice (white bar) were infected with Δm157 MC...
<p>Western blot analyses were performed on lysates from liver samples with antibodies that recognize...
<p>C57BL/6J mice were left uninfected or were infected with <i>Pb</i>ANKA, <i>Pb</i>NK65 or <i>Pc</i...
<p>BALB/c mice were treated with 1 µg/mouse IL-12 (solid square) or vehicle control (VC; open triang...
<p>BALB/c mice were injected i.v. with 5x10<sup>5</sup> PFU of WT MCMV (MW97.01) and liver tissue wa...
<p>A: Course of TGF-<i>β</i>1 expression observed by immune-staining in the liver from <i>E. multilo...